A 10-year-old girl is referred to child psychiatry for assessment of inattention and academic underperformance. Her parents report that she daydreams frequently, loses track of conversations, and forgets homework assignments despite reminders. She does not fidget excessively and sits quietly in class, but her grades have declined over the past 18 months. On cognitive testing, her IQ is average. She denies anxiety and shows no signs of depression. Her teacher notes she is well-behaved and does not disrupt the class. Neurological examination is unremarkable. Which pharmacological agent is most appropriate as first-line treatment if ADHD is confirmed?

Explanation

## First-Line Pharmacotherapy for ADHD: Methylphenidate ### Rationale for Stimulant Selection **High-Yield:** Stimulants (methylphenidate and amphetamines) are the first-line pharmacological agents for ADHD across all presentations. They increase dopamine and norepinephrine in the prefrontal cortex, enhancing executive function, attention, and impulse control. **Key Point:** This girl presents with predominantly inattentive ADHD (daydreaming, forgetfulness, inattention without hyperactivity or impulsivity). Stimulants are equally effective for all three ADHD presentations. ### First-Line Pharmacological Agents for ADHD | Agent | Class | Onset | Duration | First-Line? | |-------|-------|-------|----------|-------------| | **Methylphenidate** | Stimulant | 30–60 min | 4–6 hrs (IR) / 8–12 hrs (ER) | **Yes** | | **Amphetamine salts** | Stimulant | 30–60 min | 4–6 hrs (IR) / 8–12 hrs (ER) | **Yes** | | Atomoxetine | Non-stimulant (NRI) | 2–4 weeks | 24 hrs | Second-line | | Guanfacine | Alpha-2 agonist | 1–2 weeks | 12–16 hrs | Second-line | | Clonidine | Alpha-2 agonist | 1–2 weeks | 12–16 hrs | Second-line | **Clinical Pearl:** Non-stimulants (atomoxetine, guanfacine, clonidine) are reserved for children with contraindications to stimulants (cardiac disease, substance abuse history, severe anxiety) or inadequate response to stimulants. ### Mechanism of Action **Mnemonic: DAM (Dopamine And Methylphenidate)** — Methylphenidate blocks reuptake of dopamine and norepinephrine at the presynaptic terminal, increasing their availability in the prefrontal cortex and striatum, thereby improving attention, executive function, and impulse control. ### Efficacy Data - **Response rate:** 70–80% of children with ADHD respond to stimulants - **Onset:** Rapid (within 30–60 minutes for immediate-release formulations) - **Effectiveness across presentations:** Equally effective for inattentive, hyperactive-impulsive, and combined types ### Monitoring and Safety **Key Point:** Before initiating stimulants, obtain baseline blood pressure, heart rate, and ECG (if cardiac risk factors present). Monitor for appetite suppression, sleep disturbance, and growth velocity. **Warning:** Stimulants are contraindicated in uncontrolled hypertension, structural cardiac abnormalities, and recent MI. Screen for personal or family history of sudden cardiac death.